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SUMMARY
In this overview we discuss the role of psychiatry in
managing delirium in acute hospital admissions.
We briefly discuss the role psychiatry can offer in
four main domains: (a) assessment; (b) manage-
ment; (c) recovery; and (d) paradigm, education
and research. In the assessment section we dis-
cuss accurately detecting delirium in the context
of comorbid mixed neuropsychiatric syndromes,
including depression and dementia, and the clinical
importance of delirium subtyping. The management
section briefly outlines pharmacological and non-
pharmacological approaches to delirium and their
evidence-based rationale. The recovery section
focuses on the effect delirium can have on cogni-
tive decline, mental health and long-term health,
including functional outcome and need for institu-
tional care after hospital discharge. Finally, we out-
line the role of psychiatry in delirium research and
education. We hope that this article will encourage
clinicians to reflect on their current practice and
consider holistic and evidence-based care for this
vulnerable population in the acute hospital setting.
LEARNING OBJECTIVES
After reading this article you will be able to:
• understand the epidemiology and prognosis of
delirium in the acute hospital setting
• recognise that delirium often occurs in mixed
presentations, which may require detailed lon-
gitudinal phenomenological profiling
• appreciate the current evidence-based
approaches to delirium care in the acute hos-
pital setting
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Delirium is amajor public health concern internation-
ally; and as the biopsychosocial syndrome par excel-
lence, its management can serve as an index of the
quality of care an older patient receives in hospital
(Jackson 2017). Delirium is often defined as an
acute-onset neuropsychiatric syndrome, marked by
changes to cognitive domains (e.g. attention and
memory) and wider behavioural changes (e.g. sleep–
wake cycle and motor disturbances), occurring
in the context of medical illness (Inouye 2014).
Delirium is a complex syndrome that has a highly het-
erogeneous and fluctuating phenomenological profile,
which results in a wide differential diagnosis. The
aetiology is multifactorial and includes both modifi-
able (e.g. acute critical illness) and non-modifiable
(e.g. advanced age) risk factors (Vasilevskis 2012).
In the acute hospital setting, it has a prevalence of
20% among general medical admissions, and this
increases to over 50% in medical admissions of
older people (Davis 2013; Inouye 2014). In more
specialist clinical settings such as the intensive care
unit (ICU) and palliative care, its prevalence can
reach over 80% (Krewulak 2018; Hosie 2013). It is
associated with a variety of detrimental clinical out-
comes, including increased length of hospital stay
and increased risk of morbidity, mortality and
dementia (Inouye 2014). Delirium is also a distressing
experience for both patients and families. Indeed,
qualitative research has reported on the experiential
distress and resulting features of anxiety, depression
and post-traumatic stress-like features that patients
have following an in-patient episode of delirium
(Grover 2014; Martins 2016). Families and care-
givers are also affected by the presence of delirium
and it can increase burnout and carer distress
(Finucane 2017). Following discharge, patients often
face long-term consequences such as reduced adap-
tive functioning and an increased risk of needing insti-
tutional care (Jackson 2016). Despite all of these
factors, delirium remains clinically underdetected
and hence poorly managed in up to two-thirds of
cases (Fong 2017). Psychiatrists’ skills in assessing
complex psychopathology, coupled with specialist
knowledge of pharmacological and non-pharmaco-
logical interventions, enable them to provide the
necessary support required to help improve detection,
optimise management and support recovery.
Assessment
Delirium phenomenology and diagnosis
At present there is no gold-standard biochemical test
to accurately detect delirium (Toft 2019).
Neuroimaging has a limited role clinically in delir-
ium assessment, with current research highlighting
the non-specific findings such as cerebral atrophy
and neural dysconnectivity (Nitchingham 2018).
One study reported positive findings in only 14.5%
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of patients undergoing structural (magnetic reson-
ance imaging and computed tomography) neuroi-
maging investigations (Hijazi 2018). Therefore, in
the absence of reliable biomarkers, the detection
and assessment of delirium is informed largely by
a review of the patient’s clinical psychopathology/
phenomenology.
Although there are an estimated 340 synonyms
for delirium. depending on the clinical setting, the
consensus from the DSM-5 and ICD-10 classifica-
tion systems recognises all acute disturbances of
global cognitive functioning as delirium (World
Health Organization 1992; American Psychiatric
Association 2013). The recently available ICD-11
continues with this presentation of delirium as a clin-
ical entity (World Health Organization 2019).
Delirium is a complex syndrome reflective of gen-
eralised neural dysfunction and yet lacks a pathog-
nomonic feature. Accumulated research into the
phenomenology of delirium indicates that there are
four main domains of disturbed phenomenology:
circadian integrity, executive cognition, orders of
consciousness, and temporality (Fig. 1) (Hobson
2011; Franco 2013; Leonard 2015). Circadian
integrity is composed of two subdomains, motor
behaviour and disturbances in the sleep–wake
cycle (Fitzgerald 2013). Executive cognition refers
to such cognitive processes as attention, memory,
language and orientation (Lindroth 2019; Mitchell
2018). The third domain, the orders of conscious-
ness, are the functional modes by which executive
cognition is enabled. They are divided into
primary and secondary consciousness, but are
experienced as an integrated whole. Primary con-
sciousness refers to sensory and perceptual experi-
ence, and secondary consciousness encompasses
metacognition, i.e. awareness of one’s own thought
processes. These aspects of consciousness serve as
the modalities by which delirium, waking and
sleep consciousness possess a phenomenological
continuum (Hobson 2011). The fourth dimension
is temporality and results from the convergence of
the neurocognitive reserve of the individual and
the influence of the pathological processes on this
reserve (Cunningham 2013). This domain is critical
to detecting delirium in the acute hospital setting,
given the plethora of research highlighting the het-
erogeneity in the temporal duration of delirium fea-
tures (Kim 2018). It is clinically essential
to recognise the temporal pattern of delirium
phenomenology. Delirium has an acute onset of fea-
tures, with a prodromal change in mental state
lasting an estimated 2–3 days and including
lethargy, malaise and restlessness. A fluctuating
course is driven by disturbed circadian regulation,
with features worse at night, lasting days to weeks
in most cases (Trzepacz 2017). Taken together, an
understanding of these domains is clinically relevant
to the accurate psychiatric assessment of delirium,
which includes both a detailed longitudinal analysis
of its phenomenology and a focus on the temporal
pattern of features and their severity (Adamis 2010).
Subsyndromal delirium
Subsyndromal delirium is a state characterised by
the presence of delirium symptoms, but without
the criteria for full syndromal delirium. It is asso-
ciated with outcomes that are intermediate
between full syndromal delirium and no delirium
(Dosa 2007; Cole 2013). Although it is thought to
include many features of full syndromal delirium,
such as disturbances in motor behaviour, conscious-
ness and sleep–wake rhythmicity, a comprehensive
account has been impeded by the lack of clear diag-
nostic criteria (Boettger 2018). Although the fre-
quency of full syndromal delirium has been well
described, the frequency of subsyndromal delirium
is less well defined and is estimated to occur in
approximately 7–50% of older adult in-patients.
This wide range is likely to be due to the clinical
population studied and definition applied (Ouimet
2007; Bond 2012).
Overlapping phenomenology and complex
presentations
The diagnosis and assessment of delirium is compli-
cated by a wide differential, with depression and
dementia being especially relevant. Delirium often
exists in the context of neurocognitive disorders,
with the prevalence of delirium superimposed on
dementia reported at between 20 and 80% (Fong
2017). Delirium superimposed on dementia is asso-
ciated with a significantly higher risk of mortality,









FIG 1 Multidimensional model of delirium phenomenology.
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functional and cognitive decline compared with
delirium alone (Avelino-Silva 2017).
Although delirium is typically a transient disorder,
it is increasingly recognised that delirium is often
marked by incomplete recovery, with an estimated
20% of patients having persistent delirium that may
last months (Cole 2008). In addition, dementia with
Lewy bodies (DLB) is often described as the delir-
ium–dementia continuum owing to the presence of
shared features such as fluctuating cognition, visual
hallucinations and disturbances in the sleep–wake
cycle (Fong 2017). In a retrospective case-note
study of patients undergoing review of dementia
diagnosis at a tertiary referral unit, it was found
that delirium was more closely associated with
DLB than with Alzheimer’s disease (Vardy 2014).
A more recent study using electronic health records
highlights the significantly higher occurrence of delir-
ium in DLB than in Alzheimer’s disease (FitzGerald
2019). There is unfortunately a lack of consensus
regarding the differentiation between delirium and
dementia, which has an impact on patient care and
clinical outcomes (Richardson 2016). In the acute
hospital setting, patients with complex neurocogni-
tive features may be misdiagnosed and inappropri-
ately treated with antipsychotics, which may lead to
detrimental outcomes, given the high rate of neuro-
leptic sensitivity among people with DLB (Mueller
2017). Beyond the existence of dementia, older
patients may present with mixed neuropsychiatric
syndromes, including symptoms associated with
depression, schizophrenia and mania. Given the
non-specific manifestation of delirium phenomen-
ology, specialist review by a psychiatrist is warranted
to optimise patient care and recovery.
Delirium subtypes
Delirium can be categorised by clinically defined
subtypes, with current evidence favouring the des-
ignation of subtypes based on motor activity pro-
files. There are currently four categories of motor
subtype recognised: hyperactive, hypoactive,
mixed and none (FitzGerald 2018). It has been
reported that clinical motor subtypes of delirium
differ in several ways, including detection rates,
treatment experience, pathophysiology, duration
of delirium episode and clinical outcome.
Hypoactivity has been associated with metabolic
causes and organ failure, whereas hyperactivity is
more connected to substance-related delirium
such as delirium tremens (Morandi 2017).
Unfortunately, such studies have been found to
have inconsistent findings due to heterogeneous
methodology regarding motor subtype profiling
(FitzGerald 2018). Despite these methodological
limitations, hypoactive and mixed subtypes have
been found to have a significantly poorer prognosis,
with an estimated 1 in 3 patients dying during
their hospital admission (Avelino-Silva 2018).
Hypoactive motor profiles have been found to have
higher associated mortality independent of factors
such as comorbidity, age, delirium and severity of
dementia (Kiely 2007). The association between
hypoactive delirium and elevated mortality may be
reflective of delayed detection of delirium, and
hence more prolonged episodes (González 2009).
Conversely, hyperactive delirium is associated with
more frequent use of antipsychotics, higher detection
rates and better outcomes (Meagher 2011).
Methods to improve detection
The underdetection of delirium is the biggest chal-
lenge to optimising delirium management and
recovery (Ritter 2018). It has been reported that
delirium is particularly underdetected in the emer-
gency department and that approximately 77% of
patients with delirium in the emergency department
continue to have delirium during their hospital
admission (Han 2017).
In clinical practice, assessing delirium requires a
longitudinal perspective, which includes repeated
assessments. Such a process can be informed by
using validated tools to optimise the diagnostic
ability of ward staff and provide reliable longitudinal
assessments following review by a psychiatrist.
There are an estimated 24 delirium detection tools
available, and many have been translated into a
variety of languages (Adamis 2010). In the acute
hospital setting, both the Confusion Assessment
Method (CAM) and the 4AT have been widely
used as screening methods to help optimise delirium
detection and monitor recovery. Although the 4AT
is in widespread use in the UK’s National Health
Service (NHS) and has demonstrated high diagnos-
tic performance, the CAM has been adapted and
applied to a multitude of clinical settings, including
the emergency department and ICU as well as
numerous ward settings (Gélinas 2018; Shenkin
2019). Of the rapid bedside tests of attention and
arousal, the Observational Scale of Level of
Arousal (OSLA) and the Richmond Agitation–
Sedation Scale (RASS) have demonstrated high sen-
sitivity and specificity for detecting delirium in older
medical in-patients (Quispel-Aggenbach 2018). At
present there is no consensus regarding the
optimum routine screening system for delirium or
the best tool to use. These tools are dependent on
the training of the individuals and begin to lose
their utility when patients present withmixed neuro-
psychiatric conditions such as dementia and affect-
ive disorders. In these complex contexts, more
detailed tools have been developed and validated
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to optimise detection, such as the Delirium Rating
Scale – Revised-98 (Adamis 2010). This instrument
detects the wide variety of presenting features of
delirium, combined with severity scores for each
item and global severity scores (Trzepacz 2001).
Again, this approach requires extensive training.
In the context of subsyndromal delirium, there are
no validated assessment tools, and such a diagnosis
is based on specialist review by a psychiatrist, who
may apply an operationalised algorithm adapted
from the literature (Trzepacz 2012). In the context
of motor subtyping, several methods have been vali-
dated. These include the Delirium Motor Subtyping
Scale (DMSS) and the abbreviated 4-item DMSS.
Both these tools have been found to have high
cross-sectional and longitudinal reliability
(Fitzgerald 2016; Boettger 2017). This is clinically
helpful as it may enable ward staff to accurately
detect subtypes and monitor their features longitu-
dinally. Informal screening is consistently reported
to be insufficient to accurately detect delirium in
routine clinical practice, whereas validated screen-
ing tools and integrated diagnostic algorithms have
demonstrated reliability and feasibility across
several acute hospital settings (Grossmann 2014;
Maclullich 2019). In real-world clinical practice
each case of delirium is unique. Ward staff can be
helped by their liaison (general hospital) psychiatry
service to apply a suitable method for the particular
patient to enable the necessary longitudinal moni-
toring of patient progress and recovery.
Management
Cognitive-friendly hospitals and policy
development
The priority in approaching delirium in the acute hos-
pital setting should be to optimise the conditions for its
prevention. Indeed, comprehensive geriatric assess-
ment with a view to reducing any modifiable risks
for delirium is essential. Addressing polypharmacy is
a key priority, especially rationalising any anticholin-
ergic medications that may reduce cognitive function.
Another priority is to identify and treat underlying
causes and contributors. Delirium does not exist in
isolation, but rather in a complex interaction of
ward processes and acute illnesses. To provide
optimum care for the ageing population, the concept
of the cognitive-friendly hospital has emerged. The
characteristics that are required for such a hospital
according to Maclullich et al (2013) are outlined in
Box 1. In the NHS clinical context, the National
Institute for Health and Care Excellence (NICE)
(2010) offers guidelines at a national level (Clinical
Guidelines CG103) that can be adapted to the individ-
ual hospital setting. These guidelines describe the
current evidence in four key domains: (a) risk factor
assessment; (b) interventions to prevent and manage
delirium; (c) delirium screening and assessment; and
(d) information, support and communication.
Unfortunately, national and international evidence
reports on the persistent gap between delirium policy
guidelines such as NICE CG103 and their application
through associated quality standards (such as NICE
QS63; NICE 2014) (Lamond 2018).
Liaison psychiatry can offer a valuable contribu-
tion to local, regional and national policy develop-
ment and hospital management structures with a
view to improving care beyond the unit of the
patient or ward. The Royal College of Psychiatrists
has highlighted the role liaison psychiatry can offer
by supporting ward staff to apply these guidelines
in the real-world clinical setting (Royal College of
Psychiatrists 2013, 2019a).
Multicomponent interventions and liaison
psychiatry multidisciplinary teams
The current evidence recommends that multicompo-
nent interventions are the first-line management and
prevention strategy for delirium in the acute hospital
setting. These interventions consist of nurse-led
enhanced care plans that minimise and contain modi-
fiable risk factors for delirium, such as dehydration,
immobility, pain and malnutrition (Teale 2017;
Oberai 2018). In addition to the liaison psychiatry
service, the delivery of multicomponent interventions
wouldbe supported by othermembers of themultidis-
ciplinary team such as physiotherapists (mobility
recovery), dieticians (patient nutrition) and elder
care physicians (comprehensive geriatric assessment).
In the largest and most up-to-date systematic
review and meta-analysis on the subject, Hshieh
et al (2018) appraise the impact and implementation
of multicomponent interventions on delirium detec-
tion and management in the acute hospital setting.
In total, 44 studies set in a wide variety of inter-
national (USA, Europe and South America) acute
hospital settings were included in the systematic
review and 14 of those were included in the meta-
analysis. The authors concluded that the evidence
BOX 1 Key characteristics of cognitive-friendly
hospitals
• Guidelines for the prevention and management of
delirium
• Routine delirium screening
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supported the implementation of multicomponent
interventions in the acute hospital setting to reduce
delirium incidence, the rate of patient falls, the
length of hospital stay and the rate of transfer to
long-term institutional care. Six of the included
studies explored barriers and facilitators in imple-
menting this approach to delirium care. The key
facilitators included clinician leadership and chan-
ging organisational culture. However, the most
prominent facilitator was the implementation of
the policy measure to identify and empower an
administrative champion (also known as a delirium
champion). Ward-based nursing staff are in a key
position to adopt this role, which could be supported
by the liaison psychiatry service.
Given the prevalence and acute critical care needs
of patients with delirium, nursing staff are in an
important position to initiate multicomponent inter-
ventions and deliver routine delirium screening.
However, neither NICE nor the Royal College of
Nursing endorses any particular methods of imple-
menting these interventions. International and
national evidence suggests that, in the absence of
routine patient screening or educational training
for ward staff, patients with delirium may be
missed and hence not treated appropriately (NICE
2014; Saczynski 2014; Yue 2014). In qualitative
and quantitative studies on nurses’ experience, per-
ceptions and management of delirium, the most con-
sistent barrier reported is the lack of detail on
implementation of policy/guidelines regarding delir-
ium detection and management. In particular,
respondents reported a lack of guidance on how to
apply key factors identified in the literature, which
include: nursing screening and detection of delirium;
training and education for nurses; and guidelines on
management of delirium in the acute hospital setting
(Fan 2012; Awad 2019). Therefore, liaison psych-
iatry service input focused on these domains may
be a suitable approach to operationalising profes-
sional delirium guidelines and delivering optimum
delirium care for patients in the acute hospital
setting. This approach would also help coordinate
patient care and provide additional support to the
role of family members/caregivers.
Delirium care can also benefit from input from the
wider liaison psychiatry multidisciplinary team and,
in addition to the role doctors can offer, liaison
psychiatry nurses have invaluable roles in areas
such as detection of delirium, monitoring treatment
efficacy, role-modelling good care, and giving pre-
scribing advice. Such input can be further supported
by the provision of high-quality mediation skills to
help ward teams coordinate care with patients and
families. Finally, the use of assessments under the
Mental Capacity Act, Deprivation of Liberty
Safeguards (DoLS) and occasionally the Mental
Health Act 1983 may be required to support man-
agement of patients with a delirium whose risks
are significant. Such expertise can enable ward
teams to support patients within the appropriate
legal framework and protect patient rights.
Pharmacotherapy
Specialist knowledge of psychotropic medication is
another key service that psychiatry can offer in the
management of delirium. The current consensus
regarding the pharmacological management of delir-
ium proposes that psychotropic medication be used
with caution and only for situations that have not
yielded to non-pharmacological interventions (NICE
2010, 2014). Research has indicated that patients
presenting with hyperactive delirium tend to be pre-
scribed antipsychotics more frequently, likely owing
to the distress and or the psychotic symptoms experi-
enced (Meagher 2011). Conventionally, the anti-
psychotic of choice is haloperidol, given its absence
of anticholinergic side-effects (Yoon 2013). The use
of antipsychotics is controversial, and there is little
evidence to indicate that they should be used to
treat delirium directly (Neufeld 2016; Burry 2018).
In congruence with this, there is no robust evidence
to suggest that at-risk patients should be given anti-
psychotics prophylactically (Oh 2019).
Generally, antipsychotics are associated with a
wide variety of adverse effects, such as prolonged
QTc, torsades de pointes, and extrapyramidal and
anticholinergic side-effects (Huhn 2019). In the
context of delirium, antipsychotics have been found
to be relatively safe if given for the duration of the
detected delirium, for example 3–7 days. In a pro-
spective observational study of 2453 acutely admit-
ted patients who experienced an episode of
delirium, it was found that approximately 1% experi-
enced an adverse event attributable to antipsychotic
use. Of note, the authors found no deaths attributable
to antipsychotic use (Hatta 2014). However, caution
must be used when DLB is suspected, particularly
in the context of spontaneous Parkinsonism, rapid
eye movement (REM) sleep behaviour disorder or
visual hallucinations preceding acute cognitive
decline (McKeith 2017).When required, antipsycho-
tics should be prescribed for distress/agitation
during the delirium episode where the patient may
be a risk to themselves or others. They should be pre-
scribed at the lowest effective dose for the shortest
period and regularly reviewed for efficacy (NICE
2010, 2014). Psychiatry can offer additional advice
and recommendations on the choice of antipsychotic
if a patient’s clinical profile requires a more careful
consideration of its pharmacological properties,
taking into consideration, for example, route of
administration, comorbidities such as Parkinson’s
Delirium in the acute hospital setting
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disease, cardiac history, and history of falls and
hypotension. However, it is highly recommended
that antipsychotics are reviewed prior to discharge
and discontinued wherever possible, given the con-
sistent finding that approximately a quarter of anti-
psychotics initiated for older patients in acute
hospital settings continue after discharge (Herzig
2016; Loh 2014).
Finally, there is no evidence to support the use of
benzodiazepines in managing delirium not asso-
ciated with alcohol withdrawal (Lonergan 2009).
There is limited emerging evidence to suggest that
dexmedetomidine (an alpha-2 adrenergic agonist)
may be a reasonable alternative to antipsychotics
to manage agitation in ventilated ICU patients
(Flükiger 2018). More recent studies have proposed
that novel substances such as melatonin may have
clinical utility due to its effect on sleep, but there is
insufficient evidence to endorse this in the main-
stream approach to delirium (Chen 2016).
Models of delirium care
As a psychiatry subspecialty, liaison psychiatry oper-
ates in the main via a ‘referral–response’ model,
although models and composition of teams vary.
This reactive (as opposed to proactive) model may
risk missing opportunities for implementing prevent-
ive and earlymanagement strategies that may lead to
improved outcomes for those at risk of delirium. The
Royal College of Psychiatrists, for example, recom-
mends that age-inclusive services have suitable
embedded expertise to meet the specific needs of
older people (Royal College of Psychiatrists 2019b).
Interest is growing in more integrated models of
liaison psychiatry, although the evidence base for
clinical effectiveness and cost-effectiveness is in
development. The ongoing HOME study based in
the UK is a notable example of developing a more
proactive approach to psychological medicine in the
acute hospital setting (Walker 2019).
Although this article, and indeed the majority of lit-
erature on delirium, pertains to the acute hospital
setting, it should be acknowledged that delirium
occurs in a range of settings and therefore psychiatrists
need to acquire skills in delirium management as a
core aspect of their training. In addition to this consid-
eration, integrated caremodels outside the typical hos-
pital ward model are something to aspire to and have
been implemented in some settings: a good example is
the management and recovery approach to post-
operative delirium (McDonald 2018).
Recovery
The impact and experience of delirium
Owing to its wide-ranging impact, recovery from
delirium must be considered from different
perspectives, which include cognition, physical
health and mental health. Recovery is also informed
by each patient’s particular journey through the
acute hospital setting. For example, patients pre-
senting with delirium to the emergency department
tend to have significantly longer hospital stays,
higher 30-day mortality rates and higher 30-day
readmission rates (Kennedy 2014). Such vulnerable
patients have significantly higher rates of admission
to the ICU and transfer to post-acute institutional
care facilities on discharge from hospital (Han
2009; Kennedy 2014).
In the ICU setting, delirium is associated with an
increased risk of mortality both during admission
and following discharge. In this setting, delirium is
associated with an increased ICU length of stay
and patients are significantly more likely to
undergo tracheostomy. It is also associated with pro-
longed mechanical ventilation time and total hos-
pital length of stay (Mehta 2015). Post-operative
delirium has been found to be associated with an
increased rate of ICU stays that last more than 5
days, significantly higher rate of 30-day readmis-
sions to acute hospital and higher rate of discharge
to a permanent care home placement (Raats
2015). When patients are discharged to a post-
acute care facility following an episode of delirium
it has been reported that they have significantly
increased risk of mortality and higher 30-day acute
hospital readmission rates (Kosar 2017). Taken
together these clinical factors may have a detrimen-
tal impact on patient recovery in both cognitive and
wider functional domains.
Not surprisingly, delirium is a distressing experi-
ence for patients, families, carers and healthcare
staff (Grover 2014; Martins 2016). Qualitative
research has reported on the experiential distress
and resulting features of anxiety and depression
that patients have after an in-patient episode of delir-
ium (Whitehorne 2015). In particular, post-trau-
matic stress disorder (PTSD) is emerging as a
recognised consequence of delirium and it has been
suggested that it should be more routinely followed
up, given its potential impact on patient recovery
and quality of life (Teale 2013; Bolton 2019).
However, many patients do not report their symp-
toms as they feel that the delirium experience is evi-
dence of a severe mental illness associated with
stigma (Kim 2017). As mentioned earlier, the pres-
ence of delirium can increase burnout and carer dis-
tress in families and caregivers (Finucane 2017).
Patient recovery can be optimised, however, by
engaging with orientation strategies and emotional
support, which can significantly ameliorate the
experiential distress of delirium (Halloway 2014).
Consultation with liaison psychiatry services may
offer advice regarding suitable support that patients
FitzGerald & Price
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and their families may require following discharge
from hospital. However, given the growing literature
highlighting the need for follow-up in the context of
PTSD, mood and anxiety symptoms, service devel-
opment to set up brief post-discharge clinical
liaison clinics may be warranted.
The interface between delirium and dementia
Recovery from delirium is an ill-defined concept in
the literature, and although it is widely considered
that delirium is often reversible, accumulating evi-
dence suggests that it is often marked by incomplete
resolution (Witlox 2010; Adamis 2014). Indeed, it
has been found that, for each day a patient has delir-
ium in the emergency department, a significantly
worse long-term cognitive and functional outcome
has been reported (Han 2017). It has also been
reported in a systematic review of 18 cohort
studies that the proportions of patients with persist-
ent delirium at point of discharge and at 1, 3 and 6
months are approximately 44.7%, 32.8%, 25.6%
and 21% respectively (Cole 2008). According to
Inouye et al (2014), delirium can be a marker of
the vulnerable brain, with a reduction in reserve cap-
acity to withstand noxious insults. Therefore, delir-
ium has a negative impact on the trajectory of
normal cognitive ageing by adding a series of punc-
tuated stages of decline and recovery associated with
each episode of delirium (Fong 2017). These insults
on cognitive function can consequently increase the
risk in some vulnerable patients of developing
dementia. This further reinforces the complex inter-
face between delirium and dementia, and the post-
discharge cognitive trajectory towards dementia
that many patients with delirium may develop in
the community (Fong 2015). To tackle this chal-
lenge, follow-up review of patients in the regional
older people’s mental health service (e.g. memory
clinics) may help support patients and families to
address the challenge and trajectory of cognitive
impairment.
Paradigm, education and research
Good practice in the identification, assessment and
management of delirium is a ‘life skill’ for medical
professionals, especially those working with older
people, but because the condition straddles the trad-
itional separation of ‘mind’ and ‘body’ medicine it
risks being neglected in more specialty-focused
medical training programmes and therefore remain-
ing underrecognised even in acute medical settings.
Delirium may be most easily recognised when
there is an obvious change in behaviour, psychiatric
symptoms or difficulty in providing medical care.
This may have contributed to a culture in which
delirium is commonly conceptualised as a
‘psychiatric’ problem (albeit with an ‘organic’
underlying cause). An improvement in practice
therefore requires a shift in culture whereby training
in good delirium care is everybody’s business and
core to medical training throughout.
To optimise delirium detection, management and
recovery in the acute hospital setting, further educa-
tional support and research approaches are war-
ranted. Psychiatry as a discourse and as a practice
can inform the multidisciplinary research required
to improve the development of screening methods
and routine profiling approaches across the clinical
settings in which delirium is most manifest. At the
centre of this issue is the role of phenomenology,
which has often been cited as the rationale for the
different approaches taken to manage delirium
(Meagher 1998). Indeed, future pharmacotherapy
trials may adapt their approach to targeting specific
features of delirium, namely positive psychotic
symptoms or perhaps clinical subtypes (e.g. hypoac-
tive versus hyperactive) to yield more innovative
findings. Moreover, the complex interface between
delirium and dementia requires further investigation
with a view to creating more reliable methods of
either differentiating between these two neurocogni-
tive syndromes, or identifying methods that can
measure the impact of delirium on the vulnerable
brain. In particular, neuroimaging combined with
detailed phenomenological profiling may yield
such benefits, particularly in elucidating the inter-
face between delirium and DLB.
Gaps in knowledge and training have consistently
been cited as critical barriers to implementing best
practice care for people with delirium. Knowledge
pertaining to screening, risk factor detection and
reduction, and management of distress/psychosis
are often cited as recurrent themes. Congruent with
this, the 2011 National Audit of Dementia in acute
hospitals in England and Wales found that only
one-third of staff felt they had received adequate
training or guidance in dementia care (Royal
College of Psychiatrists 2012). In addition, ward
teams may be uncertain about the optimal approach
to engage with the specific processes of discharge
planning, specialist out-patient referrals, older adult
mental health requirements, and more intimate dis-
cussions with patients and families regarding the
experience and impact of delirium. Liaison psych-
iatry services are well positioned to work collabora-
tively with ward teams to deliver the quality and
provision of such information and skills. However,
it is important to reiterate the importance of liaison
psychiatry services delivering specific expertise in
managing the needs of older people as compared
with those of the younger adult population. This
has been highlighted by the Royal College of
Psychiatrists in a recent position statement (Royal
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College of Psychiatrists 2019a). Such an approach
may enable the ward team to enhance its capacity
to implement best-practice guidelines when engaging
with patients with delirium and to improve the
general approachwith this vulnerable patient cohort.
Discussion
Delirium is an acute-onset neuropsychiatric emer-
gency that presents across multiple acute clinical
care settings. This article has outlined the different
forms of support psychiatry can offer (Fig. 2).
Psychiatry teams can provide assessment in the
context of complex neuropsychiatric phenomen-
ology and its impact on patients’ mental health.
Moreover, the liaison psychiatry service can work
collaboratively with the ward team to optimise
patient management and monitor its efficacy.
Psychotherapeutic and general mediation skills
can help support ward teams, families, carers and
patients to aid in recovery from delirium. Old age
psychiatrists are particularly skilled in dealing
with the impact of delirium on cognitive functioning
and advanced dementia. Indeed, the versatility of
contemporary older people’s mental health services
enables psychiatry to offer a coherent and invaluable
approach to delirium across domains.
Delirium is not a condition that exists in isolation
and it is often the outcome of the general approach to
care of the older patient in the acute hospital setting.
Hence, a more multifaceted approach may have a
positive impact on delirium prevention, detection
and management. Therefore, robust policy and
practice initiatives are required to reconstruct and
adapt the hospital setting to address the acute care
needs of the ageing population across various clin-
ical settings. Psychiatry is in a key position to
support the optimisation of care regarding delirium
in the acute hospital setting and provide a meaning-
ful contribution to the evolving elder care discourse.
Although perhaps as important as any of the crucial
clinical contributions that psychiatry can offer
would be a change in perspective so that delirium
is regarded as an index of the quality of care that
patients can receive in the acute hospital setting.
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MCQs
Select the single best option for each question stem
1 The estimated frequency of antipsychotic
prescriptions initiated for older patients in







2 Of the following subtypes of delirium, the
best clinical outcomes are for:
a hyperactive
b hypoactive
c hypoactive and mixed
d mixed
e hyperactive and mixed
3 A recommended first-line treatment in
managing delirium is:
a an enhanced care plan
b single component interventions
c multicomponent interventions
d admission to a mental health ward
e watch and wait approach
4 As regards the pharmacotherapy of delirium:
a there is robust evidence to support the use of
atypical over typical antipsychotics in managing
delirium
b the use of antipsychotics is controversial and
there is little evidence to indicate that they
should be used to treat delirium directly
c typical antipsychotics such as haloperidol should
be used prophylactically to reduce delirium
d risperidone is the antipsychotic of choice for
managing delirium
e olanzapine is the antipsychotic of choice for
managing delirium
5 The estimated proportion of patients with
persistent delirium at 6 months post-dis-
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